BIOLASE Inc expected to post a loss of $2.55 a share - Earnings Preview

* BIOLASE Inc is expected to show a fall in quarterly revenue when it reports results on March 21 for the period ending December 31 2023

* The Foothill Ranch California-based company is expected to report a 3.6% decrease in revenue to $13.549 million from $14.05 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

* ​LSEG's mean analyst estimate for BIOLASE Inc is for a loss of $2.55 per share.

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

* The mean earnings estimate of analysts was unchanged in the last three months. ​

* Wall Street's median 12-month price target for BIOLASE Inc is $8.75​, above​ its last closing price of $0.14. ​​​

The company's guidance on May 11 2023 for the period ended December 31 was for gross profit margin of 50%. Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI

ENDING ARTESTIMAT ESTIMATE MET, SE %

E® MISSED

Sep. 30 2023 -1.85 -1.85 -3.89 Missed -110.3

Jun. 30 2023 -4.00 -5.33 -8.24 Missed -54.5

Mar. 31 2023 -21.31 -19.67 -18.00 Beat 8.5​

Dec. 31 2022 -64.18 -63.67 -1.28 Missed -101

hundred

​​Sep. -84.76 -84.33 -1.10 Missed -30.4

30 2022 hundred

Jun. 30 2022 -63.50 -62.25 -91.00 Missed -46.2​

Mar. 31 2022 -79.00 -68.00 -81.00 Missed -19.1

Dec. 31 2021 -62.50 -75.00 Missed -20

This summary was machine generated March 19 at 21:29 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)